Announced Mon, 28 Jul · 14:30 IST

Fischer Medical Ventures Limited has informed the Exchange that the Board of Directors at its meeting held on July 28, 2025, has considered and approved subdivision of 64851547 equity shares of 10 each into 648515470 equity shares of 1 each.

Stock SplitCorporate Actions View source PDF

FISCHER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Fischer Medical Ventures Limited has approved a stock split, subdividing each equity share of face value Rs. 10 into 10 equity shares of face value Rs. 1 each. Currently, the company has 6,48,51,547 equity shares of Rs. 10 (paid-up capital of Rs. 64.55 crore); post-split, this will become 64,85,15,470 shares of Rs. 1 (same total capital). The split is subject to shareholder approval via postal ballot, with e-voting scheduled from July 31, 2025 to August 30, 2025, and the record date will be announced separately. The company says the rationale is to make shares more affordable for retail investors and improve liquidity. The Memorandum of Association will also be amended to reflect the new face value.

Likely market impact

The stock price will adjust proportionally (theoretically trading at roughly one-tenth of the pre-split price), so the total value of each shareholder's holding remains unchanged. Existing shareholders will automatically hold 10 times more shares. The move may improve liquidity and broaden retail participation, but it does not change the company's fundamentals or market value.